Have a feature idea you'd love to see implemented?
Let us know!
OPK Opko Health Inc
Price (delayed)
$1.56
Market cap
$1.06B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.18
Enterprise value
$1.16B
Opko Health Inc. is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and
Highlights
Opko Health's quick ratio has soared by 89% YoY
Opko Health's EPS has increased by 45% from the previous quarter and by 36% YoY
The debt has soared by 94% QoQ and by 74% YoY
The gross profit has contracted by 46% YoY and by 4.1% from the previous quarter
Key stats
What are the main financial stats of OPK
Market
Valuations
Earnings
Shares outstanding
682.48M
Market cap
$1.06B
Enterprise value
$1.16B
Price to earnings (P/E)
N/A
Price to book (P/B)
0.78
Price to sales (P/S)
1.52
EV/EBIT
N/A
EV/EBITDA
61.27
EV/Sales
1.63
Revenue
$711.41M
EBIT
-$81.18M
EBITDA
$18.94M
Free cash flow
-$198.22M
Per share
Balance sheet
Liquidity
EPS
-$0.18
Free cash flow per share
-$0.29
Book value per share
$2.01
Revenue per share
$1.02
TBVPS
$1.55
Total assets
$2.26B
Total liabilities
$852.69M
Debt
$502.24M
Equity
$1.4B
Working capital
$417.98M
Debt to equity
0.36
Current ratio
2.97
Quick ratio
2.42
Net debt/EBITDA
5.06
Margins
Efficiency
Dividend
EBITDA margin
2.7%
Gross margin
25.1%
Net margin
-18.8%
Operating margin
-26.4%
Return on assets
-6.5%
Return on equity
-9.8%
Return on invested capital
-9.7%
Return on capital employed
-4%
Return on sales
-11.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OPK stock price
How has the Opko Health stock price performed over time
Intraday
-1.27%
1 week
-3.7%
1 month
7.59%
1 year
3.31%
YTD
3.31%
QTD
4.7%
Financial performance
How have Opko Health's revenue and profit performed over time
Revenue
$711.41M
Gross profit
$178.56M
Operating income
-$187.97M
Net income
-$133.73M
Gross margin
25.1%
Net margin
-18.8%
OPK's operating margin has dropped by 60% year-on-year but it is up by 29% since the previous quarter
The gross profit has contracted by 46% YoY and by 4.1% from the previous quarter
The net margin has increased by 45% QoQ and by 21% YoY
The net income is up by 45% since the previous quarter and by 36% year-on-year
Growth
What is Opko Health's growth rate over time
Valuation
What is Opko Health stock price valuation
P/E
N/A
P/B
0.78
P/S
1.52
EV/EBIT
N/A
EV/EBITDA
61.27
EV/Sales
1.63
Opko Health's EPS has increased by 45% from the previous quarter and by 36% YoY
The P/B is 28% below the 5-year quarterly average of 1.1 but 13% above the last 4 quarters average of 0.7
Opko Health's equity has decreased by 2.8% YoY
The company's revenue fell by 18% YoY
The P/S is 18% above the last 4 quarters average of 1.3 and 10% above the 5-year quarterly average of 1.4
Efficiency
How efficient is Opko Health business performance
OPK's ROIC has soared by 67% since the previous quarter and by 67% year-on-year
Opko Health's ROS has soared by 63% from the previous quarter and by 51% YoY
The ROA has grown by 46% from the previous quarter and by 33% YoY
The ROE has increased by 45% QoQ and by 28% YoY
Dividends
What is OPK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OPK.
Financial health
How did Opko Health financials performed over time
The company's total assets is 165% higher than its total liabilities
Opko Health's quick ratio has soared by 89% YoY
Opko Health's current ratio has soared by 82% from the previous quarter and by 67% YoY
The debt is 64% lower than the equity
The debt has soared by 94% QoQ and by 74% YoY
The debt to equity has soared by 89% since the previous quarter and by 80% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.